Clinical Trials Logo

Filter by:
NCT ID: NCT05373108 Completed - Clinical trials for Cardiac Allograft Vasculopathy

Endothelin-1 and Cardiac Allograft Vasculopathy (CAV)

Start date: May 19, 2022
Phase: Phase 4
Study type: Interventional

Many patients with end-stage heart failure, a condition in which the heart fails to pump enough blood to support the body's other organs, are fortunate enough to receive a heart transplant. However, despite taking medicines aimed at blunting the immune system's response to the donor heart, some of them will develop transplant-related disease in the coronary arteries supplying their hearts. Fifty years after the first human-to-human heart transplant, this disorder-cardiac allograft vasculopathy (CAV)-remains a leading cause of long-term death and has been coined the 'Achilles' Heel' of heart transplantation. Indeed, a better understanding of how CAV occurs and improved therapies to prevent and/or slow its development are desperately needed to meaningfully impact patient outcomes. Endothelin-1 (ET-1) is a key molecular regulator of arterial health, and our prior data suggests that it is associated with accelerated CAV. In this particular study of recent heart transplant recipients, we are asking: Does ET-1 contribute to the coronary artery's capacity to dilate/constrict? To answer this question, during the cardiac catheterization at 1 year post-transplant (standard of care), we will measure blood levels of ET-1 and perform an invasive evaluation of coronary vasomotor function inn a consecutive subset of patients who will have received a 1-week course of the oral endothelin receptor antagonist (macitentan) prior this catheterization, which will allow us to test how much ET-1 contributes to coronary responsiveness. The findings from this study may provide the necessary foundation to study whether endothelin receptor antagonists are able to effectively reduce the rate of accelerated CAV.

NCT ID: NCT05372913 Completed - Depression Clinical Trials

Feasibility and Acceptability of W-GenZD vs CBT-light Teletherapy for Adolescents Seeking Mental Health Services

Start date: May 11, 2022
Phase: N/A
Study type: Interventional

The primary aim of this study is to determine the feasibility and acceptability of the W-GenZD mobile application among a group of adolescents and who have screened and triaged into low-intensity treatment within the Children's Hospital of the King's Daughters. The secondary aim of this study is to determine the preliminary comparative efficacy of W-GenZD and CBT-light teletherapy zoom groups to manage mood concerns at 4-weeks end of treatment relative to baseline. The third aim of this study is to investigate potential differences between group differences on working alliance. An exploratory aim of this study is to observe and describe the utilization and outcomes of the safety procedures utilized within this study.

NCT ID: NCT05372705 Completed - Anxiety Clinical Trials

Reducing Eco-anxiety Using Selfies

Start date: June 15, 2022
Phase: N/A
Study type: Interventional

The purposes of this study are to test among adolescent viewers the utility of selfie (TikTok) short video-based interventions to: 1. Reduce ecological anxiety, 2. Increase ecological agency, 3. Compare two different types of messaging, and 4. Examine the role of viewer's gender and race as independent factors on the outcomes of interest.

NCT ID: NCT05372328 Completed - Hypertension Clinical Trials

ARMS: The Arm Rest and Support Study

ARMS
Start date: August 9, 2022
Phase: N/A
Study type: Interventional

Primary Objectives 1. Determine the effect of an unsupported and poorly positioned arm on initial and average triplicate blood pressure done according to clinical practice guidelines with an automated device. a. Hypothesis: Compared to blood pressure measurements obtained with the arm supported with mid-cuff positioned at heart level, blood pressures measured with an unsupported arm and/or with mid-cuff below heart level will be significantly higher. Secondary Objective 1. To determine if the effects differ based on the following patient characteristics: - Hypertensive blood pressure (SBP≥130 mmHg vs. <130 mmHg). - Age (≥ 60 years vs. < 60 years) Greater vascular stiffness > lesser vascular stiffness - Regular health care (Last BP measured >1 year ago vs. ≤1 year ago) - Arm length:cuff width

NCT ID: NCT05372315 Completed - Cataract Clinical Trials

Efficacy of Dextenza Insert in Upper vs Lower Punctum Following Cataract Surgery With PCIOL.

DEXTENZA
Start date: June 15, 2022
Phase: Phase 4
Study type: Interventional

To assess the safety and effectiveness of treatment with an intracanalicular dexamethasone (0.4mg) insert in the operating room following cataract surgery/intraocular lens implant (IOL) with or without iStent/Hydrus/Goniotomy when placed in the lower punctum compared to the upper punctum.

NCT ID: NCT05372185 Completed - Anxiety Disorders Clinical Trials

Expanding Reach of Evidence-based Psychotherapy for Veterans With Co-occurring Anxiety and Substance Use Disorders.

Start date: April 25, 2022
Phase: N/A
Study type: Interventional

The current study seeks to better understand how to improve access to evidence-based psychotherapy (EBP) for rural Veterans with co-occurring anxiety and substance use disorders (SUD) using a web-based cognitive behavioral therapy tool (VA Coordinated Anxiety Learning and Management, Substance Use Version; VA CALM-S).

NCT ID: NCT05372107 Completed - Dry Eye Disease Clinical Trials

A Study of AG-80308 in Dry Eye Patients

Start date: June 13, 2022
Phase: Phase 1
Study type: Interventional

This is a multicenter, double-masked, randomized, parallel-group study with topical AG-80308 eye drops in dry eye patients.

NCT ID: NCT05372094 Completed - Hearing Loss Clinical Trials

Noise Reduction Preferences in Teenagers and Pre-teens

Start date: February 23, 2023
Phase: N/A
Study type: Interventional

Noise reduction preferences and blue tooth access to hearing aid streaming features will be evaluated in experienced hearing aid users age 10-17.

NCT ID: NCT05372042 Completed - Clinical trials for Posttraumatic Stress Disorder

CBT Texts for PTSD & Hazardous Drinking (Project Better)

Start date: October 31, 2022
Phase: N/A
Study type: Interventional

The research study seeks to refine and test a brief, self-directed, intervention for individuals from the general public with PTSD and co-occurring HD that can be delivered via text-messaging. This application seeks to refine the intervention further by testing whether theoretically-driven, evidence-based strategies from basic cognitive psychology (message framing) and social psychology (facilitating growth mindsets) result in better outcomes for PTSD symptoms and HD by addressing pilot participant feedback related to avoidance and motivation.

NCT ID: NCT05372003 Completed - Atopic Dermatitis Clinical Trials

IL-4 and Insulin Resistance for Treatment of Patients With Atopic Dermatitis

Start date: August 9, 2022
Phase: Early Phase 1
Study type: Interventional

The purpose of this study is to better understand the interactions between the innate immune system, in particular eosinophils, their secreted cytokines (interleukin-4), and metabolism in human health and disease states such as obesity and insulin resistance.